7 Hills Pharma LLC

2450 Holcombe Blvd, Suite J
United States

Show jobs for this employer

1 article about 7 Hills Pharma LLC

  • 7 Hills Pharma LLC announced that it has been awarded $13.5MM in nondilutive grant funds from the Cancer Prevention & Research Institute of Texas to advance 7HP349, its first-in-class oral selective integrin activator into a Phase 1b/2a clinical trial in patients who are resistant to PD-1-based therapies.